February 22, 2016
Gilead Launches New Grants Program to Support HIV Cure
– Grants to Directly Benefit Organizations Engaged in HIV Cure Activities –
“For the past 25 years, Gilead has worked toward the goal of discovering
and developing safe and effective treatments for people living with HIV.
The best possible treatment would eradicate HIV entirely, and this has
been a significant focus for the company’s research organization over
the last seven years,” said
Gilead will support four areas with grant funding:
Translational Research– proof of concept and early translational research supporting novel HIV reservoir-targeting therapeutic interventions; development of assays that would be used to evaluate the HIV reservoir and assess the impact of therapeutic interventions; exploration of the HIV reservoir and the impact of therapeutic interventions in acutely HIV-infected individuals.
- Efficacy Studies in Animal Models – animal models of AIDS to test novel therapeutic concepts targeting the HIV reservoirs and/or enhancing the immune control of AIDS viruses.
- Institutional Funding – institutional programs currently engaged in HIV cure research.
- Community Groups – research among HIV-infected individuals and affected communities to understand potential concerns related to HIV cure clinical research.
Organizations interested in applying for a grant must be classified as a
not-for-profit organization or institution. The deadline to submit the
letter of intent is
For more information on
Gilead Sciences, Inc.
Ryan McKeel, 650-377-3548 (Media)